{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T23:52:09Z","timestamp":1784332329779,"version":"3.55.0"},"reference-count":28,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2006,6,9]],"date-time":"2006-06-09T00:00:00Z","timestamp":1149811200000},"content-version":"vor","delay-in-days":373,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1080\/13556210500123514","type":"journal-article","created":{"date-parts":[[2005,9,7]],"date-time":"2005-09-07T06:16:15Z","timestamp":1126073775000},"page":"165-169","source":"Crossref","is-referenced-by-count":19,"title":["Low efficacy of non-opioid drugs in opioid withdrawal symptoms"],"prefix":"10.1111","volume":"10","author":[{"given":"Derik","family":"Hermann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eckard","family":"Klages","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helga","family":"Welzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Croissant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2006,6,9]]},"reference":[{"key":"10.1080\/13556210500123514-BIB1|cit1","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1159\/000139348","article-title":"Ethanol-induced alterations in beta-endorphin levels in specific rat brain regions: modulation by adenosine agonist and antagonist","volume":"51","author":"Anwer","year":"1995","journal-title":"Pharmacology"},{"key":"10.1080\/13556210500123514-BIB2|cit2","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1360-0443.1990.tb01665.x","article-title":"Withdrawal symptoms and alcohol dependence: fruitful mysteries","volume":"85","author":"Edwards","year":"1990","journal-title":"Br J Addict"},{"key":"10.1080\/13556210500123514-BIB3|cit3","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0024-3205(88)90108-7","article-title":"Cocaine influences beta-endorphin levels and release","volume":"43","author":"Forman","year":"1988","journal-title":"Life Sci"},{"key":"10.1080\/13556210500123514-BIB4|cit4","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/0024-3205(89)90167-7","article-title":"Different pituitary beta-endorphin and adrenal cortisol response to ethanol in individuals with high and low risk for future development of alcoholism","volume":"45","author":"Gianoulakis","year":"1989","journal-title":"Life Sci"},{"key":"10.1080\/13556210500123514-BIB5|cit5","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/0278-5846(88)90089-9","article-title":"Comparative study in mice of flunitrazepam vs. diazepam on morphine withdrawal syndrome","volume":"12","author":"Gibert-Rahola","year":"1988","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1080\/13556210500123514-BIB6|cit6","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/1355621031000117383","article-title":"Region-dependent changes in endocannabinoid transmission in the brain of morphine-dependent rats","volume":"8","author":"Gonzalez","year":"2003","journal-title":"Addict Biol"},{"key":"10.1080\/13556210500123514-BIB7|cit7","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0014-2999(96)00599-7","article-title":"Effect of alprazolam on opiate withdrawal: a combined behavioural and microdialysis study","volume":"313","author":"Gray","year":"1996","journal-title":"Eur J Pharmacol"},{"key":"10.1080\/13556210500123514-BIB8|cit8","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1126\/science.1167428","article-title":"Morphine-dependent rats: blockade of precipitated abstinence by tetrahydrocannabinol","volume":"187","author":"Hine","year":"1975","journal-title":"Science"},{"key":"10.1080\/13556210500123514-BIB9|cit9","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0376-8716(84)90005-X","article-title":"Street pharmacology: uses of cocaine and heroin in the treatment of addiction","volume":"13","author":"Hunt","year":"1984","journal-title":"Drug Alcohol Depend"},{"key":"10.1080\/13556210500123514-BIB10|cit10","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/0024-3205(90)90366-Y","article-title":"Cocaine attenuates the severity of naloxone-precipitated opioid withdrawal","volume":"47","author":"Kosten","year":"1990","journal-title":"Life Sci"},{"key":"10.1080\/13556210500123514-BIB11|cit11","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1046\/j.1360-0443.2003.00236.x","article-title":"Understanding polydrug use: review of heroin and cocaine co-use","volume":"98","author":"Leri","year":"2003","journal-title":"Addiction"},{"key":"10.1080\/13556210500123514-BIB12|cit12","first-page":"1007","article-title":"Opioid and cannabinoid modulation of precipitated withdrawal in delta(9)-tetrahydrocannabinol and morphine-dependent mice","volume":"298","author":"Lichtman","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1080\/13556210500123514-BIB13|cit13","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/BF02244309","article-title":"Influence of different benzodiazepines on the experimental morphine abstinence syndrome","volume":"105","author":"Maldonado","year":"1991","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1080\/13556210500123514-BIB14|cit14","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.neuroscience.2004.05.047","article-title":"An in vivo profile of beta-endorphin release in the arcuate nucleus and nucleus accumbens following exposure to stress or alcohol","volume":"127","author":"Marinelli","year":"2004","journal-title":"Neuroscience"},{"key":"10.1080\/13556210500123514-BIB15|cit15","doi-asserted-by":"crossref","first-page":"RC184","DOI":"10.1523\/JNEUROSCI.21-23-j0002.2001","article-title":"Stimulation of endorphin neurotransmission in the nucleus accumbens by ethanol, cocaine, and amphetamine","volume":"21","author":"Olive","year":"2001","journal-title":"J Neurosci"},{"key":"10.1080\/13556210500123514-BIB16|cit16","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0741-8329(89)90074-8","article-title":"Acute and chronic ethanol treatment on beta-endorphin and catecholamine levels","volume":"6","author":"Patel","year":"1989","journal-title":"Alcohol"},{"key":"10.1080\/13556210500123514-BIB17|cit17","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1176\/ajp.149.11.1609b","article-title":"Use of cocaine to prevent opiate withdrawal","volume":"149","author":"Rosen","year":"1992","journal-title":"Am J Psychiatry"},{"key":"10.1080\/13556210500123514-BIB18|cit18","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1046\/j.1471-4159.2003.01584.x","article-title":"Effect of experimenter-delivered and self-administered cocaine on extracellular beta-endorphin levels in the nucleus accumbens","volume":"84","author":"Roth-Deri","year":"2003","journal-title":"J Neurochem"},{"key":"10.1080\/13556210500123514-BIB19|cit19","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1124\/jpet.300.3.932","article-title":"Endogenous opioids in dopaminergic cell body regions modulate amphetamine-induced increases in extracellular dopamine levels in the terminal regions","volume":"300","author":"Schad","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1080\/13556210500123514-BIB20|cit20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0014-2999(94)00726-N","article-title":"Naloxone reduces the neurochemical and behavioral effects of amphetamine but not those of cocaine","volume":"275","author":"Schad","year":"1995","journal-title":"Eur J Pharmacol"},{"key":"10.1080\/13556210500123514-BIB21|cit21","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1080\/13556210500123191","article-title":"Mood and affect during detoxification of opiate addicts: a comparison of buprenorphine versus methadone","volume":"10","author":"Seifert","year":"2005","journal-title":"Addict Biol"},{"key":"10.1080\/13556210500123514-BIB22|cit22","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1111\/j.0953-816X.2004.03420.x","article-title":"Beta-endorphin elevations in the ventral tegmental area regulate the discriminative effects of delta-9-tetrahydrocannabinol","volume":"19","author":"Solinas","year":"2004","journal-title":"Eur J Neurosci"},{"key":"10.1080\/13556210500123514-BIB23|cit23","doi-asserted-by":"crossref","first-page":"445","DOI":"10.3109\/00952999409109183","article-title":"Reduction of opiate withdrawal-like symptoms by cocaine abuse during methadone and buprenorphine maintenance","volume":"20","author":"Stine","year":"1994","journal-title":"Am J Drug Alcohol Abuse"},{"key":"10.1080\/13556210500123514-BIB24|cit24","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1046\/j.0953-816x.2001.01558.x","article-title":"Delta9-tetrahydrocannabinol releases and facilitates the effects of endogenous enkephalins: reduction in morphine withdrawal syndrome without change in rewarding effect","volume":"13","author":"Valverde","year":"2001","journal-title":"Eur J Neurosci"},{"key":"10.1080\/13556210500123514-BIB25|cit25","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/0028-3908(95)00032-2","article-title":"Anandamide decreases naloxone-precipitated withdrawal signs in mice chronically treated with morphine","volume":"34","author":"Vela","year":"1995","journal-title":"Neuropharmacology"},{"key":"10.1080\/13556210500123514-BIB26|cit26","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1007\/s001090050287","article-title":"Cardiovascular actions of cannabinoids and their generation during shock","volume":"76","author":"Wagner","year":"1998","journal-title":"J Mol Med"},{"key":"10.1080\/13556210500123514-BIB27|cit27","doi-asserted-by":"crossref","DOI":"10.1176\/ajp.105.5.329","article-title":"Recent progress in research on the neurophysiological basis of morphine addiction","volume":"105","author":"Wikler","year":"1948","journal-title":"Am J Psychiatry"},{"key":"10.1080\/13556210500123514-BIB28|cit28","doi-asserted-by":"crossref","DOI":"10.1016\/S0006-8993(01)02655-5","article-title":"Endogenous cannabinoid, 2-arachidonoylglycerol, attenuates naloxone-precipitated withdrawal signs in morphine-dependent mice","volume":"909","author":"Yamaguchi","year":"2001","journal-title":"Brain Res"}],"container-title":["Addiction Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1080%2F13556210500123514","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1080\/13556210500123514\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T08:19:34Z","timestamp":1591863574000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1080\/13556210500123514"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,6]]}},"URL":"https:\/\/doi.org\/10.1080\/13556210500123514","archive":["Portico"],"relation":{},"ISSN":["1355-6215"],"issn-type":[{"value":"1355-6215","type":"print"}],"subject":[],"published":{"date-parts":[[2005,6]]}}}